Oncotarget

Research Papers:

Preferential targeting of cancer stem cells in the radiosensitizing effect of ABT-737 on HNSCC

Marion Gilormini, Céline Malesys, Emma Armandy, Patrick Manas, Jean-Baptiste Guy, Nicolas Magné, Claire Rodriguez-Lafrasse and Dominique Ardail _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2016; 7:16731-16744. https://doi.org/10.18632/oncotarget.7744

Metrics: PDF 761 views  |   HTML 1341 views  |   ?  


Abstract

Marion Gilormini1,2, Céline Malesys1,2, Emma Armandy1,2, Patrick Manas3, Jean-Baptiste Guy1,2, Nicolas Magné1,2,5, Claire Rodriguez-Lafrasse1,2,4, Dominique Ardail1,2,4

1Université Lyon I, Faculté de Médecine-Lyon-Sud, Oullins, France

2Laboratoire de Radiobiologie Cellulaire et Moléculaire, EMR3738, Oullins, France

3UMS3444 BioSciences Gerland-Lyon Sud, PBES, Lyon, France

4Hospices-Civils-de-Lyon, CHLS, Pierre-Bénite, France

5Institut de Cancérologie L. Neuwirth, St Etienne, France

Correspondence to:

Dominique Ardail, e-mail: dominique.ardail@univ-lyon1.fr

Keywords: head and neck squamous cell carcinoma, ABT-737, radiation, Bcl-2 family, cancer stem cells

Received: October 16, 2015     Accepted: January 13, 2016     Published: February 26, 2016

ABSTRACT

Head and neck squamous cell carcinomas (HNSCC) are common human malignancies with poor clinical outcomes. The 5-year survival rates for patients with advanced stage HNSCC have not changed appreciably in the past few decades, underscoring a dire need for improved therapeutic options. HNSCC is frequently characterized by overexpression of anti-apoptotic Bcl-2 family members. Increased levels of these anti-apoptotic proteins have been associated with radio- and chemoresistance and poor clinical outcome. The aim of this study was to evaluate combined effects of radiation and ABT-737, a BH3-mimetic molecule, in HNSCC. Although ABT-737, as a single agent, was largely ineffective at promoting HNSCC cell death, we found that combining ABT-737 and radiation induced strong synergistic apoptosis in HNSCC cell lines and delayed tumoral growth in vivo. Moreover, we demonstrated for the first time that ABT-737, alone or in combination with radiation, can efficiently eliminate cancer stem cells (CSCs). Altogether, our results indicate that therapy targeting anti-apoptotic Bcl-2 family members could be a highly effective potential adjuvant to radiotherapy capable of targeting CSCs in HNSCC and therefore overcoming cancer recurrence and metastasis.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 7744